Applications of Biomolecular Nanostructures for Anti-Angiogenic Theranostics
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Canlas, Kevin Kent Vincent | - |
dc.contributor.author | Park, Hansoo | - |
dc.date.accessioned | 2024-07-25T12:00:30Z | - |
dc.date.available | 2024-07-25T12:00:30Z | - |
dc.date.issued | 2024 | - |
dc.identifier.issn | 1176-9114 | - |
dc.identifier.issn | 1178-2013 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/75182 | - |
dc.description.abstract | Angiogenesis is a physiological process of forming new blood vessels that has pathological importance in seemingly unrelated illnesses like cancer, diabetes, and various inflammatory diseases. Treatment targeting angiogenesis has shown promise for these types of diseases, but current anti-angiogenic agents have critical limitations in delivery and side -effects. This necessitates exploration of alternative approaches like biomolecule-based drugs. Proteins, lipids, and oligonucleotides have recently become popular in biomedicine, specifically as biocompatible components of therapeutic drugs. Their excellent bioavailability and potential bioactive and immunogenic properties make them prime candidates for drug discovery or drug delivery systems. Lipid -based liposomes have become standard vehicles for targeted nanoparticle (NP) delivery, while protein and nucleotide NPs show promise for environment -sensitive delivery as smart NPs. Their therapeutic applications have initially been hampered by short circulation times and difficulty of fabrication but recent developments in nanofabrication and NP engineering have found ways to circumvent these disadvantages, vastly improving the practicality of biomolecular NPs. In this review, we are going to briefly discuss how biomoleculebased NPs have improved anti-angiogenesis-based therapy. | - |
dc.format.extent | 13 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | DOVE MEDICAL PRESS LTD | - |
dc.title | Applications of Biomolecular Nanostructures for Anti-Angiogenic Theranostics | - |
dc.type | Article | - |
dc.identifier.doi | 10.2147/IJN.S459928 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF NANOMEDICINE, v.19, pp 6485 - 6497 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.wosid | 001256711000001 | - |
dc.identifier.scopusid | 2-s2.0-85197582920 | - |
dc.citation.endPage | 6497 | - |
dc.citation.startPage | 6485 | - |
dc.citation.title | INTERNATIONAL JOURNAL OF NANOMEDICINE | - |
dc.citation.volume | 19 | - |
dc.type.docType | Article | - |
dc.publisher.location | 뉴질랜드 | - |
dc.subject.keywordAuthor | anti-angiogenesis | - |
dc.subject.keywordAuthor | peptides | - |
dc.subject.keywordAuthor | lipids | - |
dc.subject.keywordAuthor | oligonucleotides | - |
dc.subject.keywordPlus | DRUG-DELIVERY | - |
dc.subject.keywordPlus | EXTRACELLULAR VESICLES | - |
dc.subject.keywordPlus | SMART NANOPARTICLES | - |
dc.subject.keywordPlus | EXOSOMES | - |
dc.subject.keywordPlus | APTAMERS | - |
dc.subject.keywordPlus | GROWTH | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | INFLAMMATION | - |
dc.subject.keywordPlus | MECHANISMS | - |
dc.subject.keywordPlus | PLATFORM | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Nanoscience & Nanotechnology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.